Who are Disc Medicine, Inc.'s main suppliers?

Disc Medicine, Inc. (IRON) key suppliers include: AbbVie Inc., AbbVie Inc., ABBVIE-DEUTSCHLAND-GMBH-CO-KG, ROCHE, MABWELL-THERAPEUTICS-INC and 1 more. View the full supplier network at chainsifter.com/chain/IRON.

Who are Disc Medicine, Inc.'s major customers?

Disc Medicine, Inc. (IRON) key customers include: Hercules Capital, Inc., Hercules Capital, Inc., AbbVie Inc., Carpenter Technology Corporation, GEMINI-THERAPEUTICS-INC and 3 more. View the full customer network at chainsifter.com/chain/IRON.

What sector is Disc Medicine, Inc. in?

Disc Medicine, Inc. (IRON) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Disc Medicine, Inc. Suppliers, Customers & Supply Chain (IRON)

6Suppliers

8Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Disc Medicine, Inc. (IRON) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships

3Distinct source URLs

9High confidence

0.781Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Disc Medicine, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ABBV	AbbVie Inc.	92%	Under the AbbVie Agreement, we obtained an exclusive, worldwide license, with the right to sublicense to commercial pharmaceutical and biopharmaceutical companies under certain patents and technical …
ABBV	AbbVie Inc.	92%	Reciprocal relationship from ABBV graph: Reciprocal relationship from IRON graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from IRON graph: Under the AbbVie Agreement, we obta…
ABBVIE-DEUTSCHLAND-GMBH-CO-KG	ABBVIE-DEUTSCHLAND-GMBH-CO-KG	92%	Under the license agreement with AbbVie, or the AbbVie Agreement, we obtained an exclusive, worldwide license, with the right to sublicense to commercial pharmaceutical and biopharmaceutical companie…
ROCHE	ROCHE	92%	Pursuant to the terms of the Roche Agreement and in connection with the Company's reverse merger with Gemini, the Company issued 482,313 shares of the Company to Roche for no consideration.
MABWELL-THERAPEUTICS-INC	MABWELL-THERAPEUTICS-INC	90%	In January 2023, the Company entered into an exclusive license agreement with Mabwell pursuant to which Mabwell granted the Company an exclusive and sublicensable license to certain Mabwell intellect…
GLTO	Damora Therapeutics, Inc.	72%	Reciprocal relationship from GLTO graph: 026, we had an accumulated deficit of $515.1 million. We expect to continue to incur losses for the foreseeable future. Our operating expenses and net losses …

Disc Medicine, Inc. Customers

Ticker	Name	Confidence	Evidence
HTGC	Hercules Capital, Inc.	72%	the agreement, the Company received an upfront payment of $ 0.2 million with additional consideration receivable upon the achievement of certain clinical, regulatory and sales milestones up to $ 7.0 …
HTGC	Hercules Capital, Inc.	72%	Reciprocal relationship from HTGC graph: Reciprocal relationship from IRON graph: Reciprocal relationship from HTGC graph: Reciprocal relationship from IRON graph: the agreement, the Company received…
ABBV	AbbVie Inc.	62%	Reciprocal relationship from ABBV graph: Reciprocal relationship from IRON graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from IRON graph: Reciprocal relationship from ABBV g…
CRS	Carpenter Technology Corporation	62%	Reciprocal relationship from CRS graph: Reciprocal relationship from IRON graph: Reciprocal relationship from CRS graph: Reciprocal relationship from IRON graph: Reciprocal relationship from CRS grap…
GEMINI-THERAPEUTICS-INC	GEMINI-THERAPEUTICS-INC	62%	ering from hematologic diseases. The Company was founded in October 2017. The Company’s principal offices are located in Watertown, Massachusetts. The Company is subject to a number of risks and unce…
GEMSTONE-MERGER-SUB-INC	GEMSTONE-MERGER-SUB-INC	62%	ering from hematologic diseases. The Company was founded in October 2017. The Company’s principal offices are located in Watertown, Massachusetts. The Company is subject to a number of risks and unce…
MABWELL-THERAPEUTICS-INC	MABWELL-THERAPEUTICS-INC	62%	expense ( 9,187 ) ( 1,668 ) Other external research and development expense ( 2,165 ) ( 1,832 ) Internal and other research and development expense ( 11,312 ) ( 6,748 ) Commercial expense $ ( 8,434 )…
SI	Shoulder Innovations, Inc.	62%	Reciprocal relationship from SI graph: Reciprocal relationship from IRON graph: Reciprocal relationship from SI graph: Reciprocal relationship from IRON graph: Reciprocal relationship from SI graph: …

Disc Medicine, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
IRON-DEBT	Debt stack $59.3M	90%	Market cache reports total debt of $59.3M.
IRON-DEBT-10365	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2020-12-31.
IRON-DEBT-10364	Warrants outstanding: 5.46	90%	xbrl warrant detail from xbrl 2020-12-31.

Disc Medicine, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Disc Medicine, Inc..

Disc Medicine, Inc. Ownership

Holder	Name	Confidence	Evidence
IRON-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 207 tracked holders.

Disc Medicine, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SVRA	Savara Inc.	100.00	2
RCUS	Arcus Biosciences, Inc.	100.00	2
CRS	Carpenter Technology Corporation	100.00	1	['customer']
SI	Shoulder Innovations, Inc.	100.00	1	['customer']
PHGE	BiomX Inc.	100.00	2
SNYNF	Sanofi	100.00	2
HTGC	Hercules Capital, Inc.	100.00	1	['customer']
ALEC	Alector, Inc.	100.00	2
CMPS	COMPASS Pathways plc	100.00	2
ENGN	enGene Therapeutics Inc.	100.00	2
KURA	Kura Oncology, Inc.	100.00	2
MDGL	Madrigal Pharmaceuticals, Inc.	100.00	2
SGHT	Sight Sciences, Inc.	100.00	2
MRK	Merck & Co., Inc.	100.00	2
BCYC	Bicycle Therapeutics plc	100.00	2
DYN	Dyne Therapeutics, Inc.	100.00	2
ALT	Altimmune, Inc.	100.00	2
KPTI	Karyopharm Therapeutics Inc.	100.00	2
ABBV	AbbVie Inc.	100.00	1	['customer', 'supplier']
REPL	Replimune Group, Inc.	100.00	2

Disc Medicine, Inc. Supply Chain